TrianglePUBLICATIONS · 20049936
Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: a Children's Oncology Group phase I consortium study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Pediatr Blood Cancer
- Publication date
- 2010 Apr
- First author
- Wagner LM
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Wagner LM
- type
- Author
- name
- Perentesis JP
- type
- Author
- name
- Reid JM
- type
- Author
- name
- Ames MM
- type
- Author
- name
- Safgren SL
- type
- Author
- name
- Nelson MD Jr
- type
- Author
- name
- Ingle AM
- type
- Author
- name
- Blaney SM
- type
- Author
- name
- Adamson PC
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Wagner LM
- type
- Author
- name
- Perentesis JP
- type
- Author
- name
- Reid JM
- type
- Author
- name
- Ames MM
- type
- Author
- name
- Safgren SL
- type
- Author
- name
- Nelson MD Jr
- type
- Author
- name
- Ingle AM
- type
- Author
- name
- Blaney SM
- type
- Author
- name
- Adamson PC
- type
- Author
- bibliography ids
- nci-bib-91e51b7473973560d294c351
- book metadata
- content sha256
- 83768e240b84285c4b98770c3b060146060cb39f356b3e35e39ecf94472c96ab
- document type
- citation
- dois
- 10.1002/pbc.22407
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:20049936
- immutable id
- pubmed:20049936@83768e240b84285c4b98770c3b060146060cb39f356b3e35e39ecf94472c96ab
- journal
- abbreviation
- Pediatr Blood Cancer
- issn electronic
- 1545-5017
- issn print
- 1545-5009
- issue
- 4
- name
- Pediatric blood & cancer
- nlm unique id
- 101186624
- pages
- 538-45
- volume
- 54
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 20049936
- provenance
- batch id
- 708c7929ee1eff455330
- provider
- NCBI PubMed ESummary
- record sha256
- 9942b80601562a517af4ec3ab197cf6323c1c59643a24f4892cf97052b084003
- response sha256
- d245af3dbc636ffc79325b3798c7bfda16faf0a3d796681b12b8d89bd68eb450
- retrieved at
- 2026-09-09T23:46:31.496840+00:00
- publication date
- display
- 2010 Apr
- precision
- month
- year
- 2010
- publication types
- Clinical Trial, Phase I
- Journal Article
- Research Support, N.I.H., Extramural
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: a Children's Oncology Group phase I consortium study.
Preserved source evidence · Not medical advice